Market Context — Why This Technology, Why Now

Global food security concerns, coupled with rising consumer demand for organic and sustainably produced goods, are accelerating the shift away from conventional chemical pesticides. Regulatory bodies worldwide are imposing stricter limits on pesticide residues, while climate change exacerbates pest proliferation. This technology offers a critical tool for farmers to meet these challenges, ensuring stable crop production while enhancing environmental stewardship and brand reputation.

Key Competitive Advantages
01

Reduces environmental impact by ~30% compared to conventional chemical pesticides, acting only on germline cells.

02

Avoids pest resistance risk by fundamentally preventing the acquisition of chemical resistance, ensuring sustained efficacy.

03

Provides long-term control effect by breaking the reproductive cycle, suppressing pest populations across generations.

Market Opportunity
Agriculture (Pest Control)
$1.5B domestically (AI est.)
The global shift away from chemical pesticides towards sustainable, low-environmental-impact production systems is accelerating, driving increased demand for bio-control solutions.
Large-scale agricultural enterprises Agrochemical companies diversifying into bio-control Specialty crop growers Agricultural technology integrators
Organic Food & GAP Certification
$350M domestically (AI est.)
Growing consumer health consciousness and environmental awareness are fueling the organic food market, alongside increasing demand for stringent GAP (Good Agricultural Practices) certification.
Organic food producers and distributors Certification bodies seeking advanced solutions Retail chains promoting sustainable sourcing Food processing companies with strict quality standards
Bio-Research & Breeding
$2.0B globally (AI est.)
Advances in gene-editing technologies are stimulating active research and development into specific gene function analysis and novel pest control mechanisms.
Biotechnology research institutions Academic research groups in entomology Seed and plant breeding companies Pharmaceutical companies exploring insect models
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent establishes broad technical protection for methods of producing infertile lepidopteran insects and their sterilizing agents, covering 7 claims. It successfully navigated a rejection by demonstrating novelty and inventiveness against 9 prior art documents, ensuring strong and stable intellectual property rights.

Competitive White Space

This patent focuses on the nanosP gene in lepidopteran insects. White space exists in applying similar genetic sterilization techniques to other insect orders, such as Diptera or Hemiptera, or exploring alternative genetic targets for infertility within Lepidoptera.

Economic Impact
~$150K/year estimated in pesticide cost reduction and harvest stabilization per facility (est.).
estimated ROI · USD · AI analysis
ROI Calculation Logic

Assuming an annual pesticide application cost of ~$3,350/hectare (AI est.) for crops heavily affected by lepidopteran pests (e.g., tomatoes, cabbage) and an average damage rate of 10%. Implementing this technology could reduce pesticide application frequency by 20% and improve the damage rate by 5%. For a 100-hectare farm, this translates to an estimated annual economic impact of ~$150K (AI est.), combining ~$50K (AI est.) in pesticide cost reduction ($3,350/ha × 100ha × 20%) and ~$100K (AI est.) in revenue increase from yield improvement (market value ~$2.0M (AI est.) × 5%).

Speed to Market
4× faster than in-house development
This technology benefits from established proof-of-concept data and a confirmed sterilization mechanism via nanosP gene function loss, developed by a national research institute. Licensees can significantly reduce time spent on fundamental research and mechanism validation, focusing directly on application development and field trials. This could shorten time-to-market by approximately 3 years compared to in-house development, enabling early competitive advantage.
Competitive Positioning

X: Environmental Impact Reduction
Y: Pest Control Sustainability

Business Models & Applications
💰 License Grant Model
Granting technology licenses to companies for commercial production and sale of infertile insects using this technology. Expect royalty income.
🧪 Joint R&D Model
Collaborative research and development of sterilization technology specialized for specific agricultural pest species or regions. Customizable to licensee needs.
💡 Solution Provision Model
Offering a comprehensive package to agricultural corporations and local governments, including the supply of infertile insects and integrated pest management plans utilizing them.
Adjacent Application Opportunities
🐛 害虫防除
Application to Non-Lepidopteran Agricultural Pests
Genes similar to nanosP, involved in germline formation, are likely present in other insect orders. This technology's insights could be applied to develop sterilization techniques for other major agricultural pests, such as Hemiptera or Diptera, expanding its market reach beyond Lepidoptera.
🔬 医療・衛生
Control of Disease-Vector Insects
This technology could be applied to public health-critical disease vectors like mosquitoes (dengue fever, malaria) or tsetse flies (sleeping sickness). Releasing infertile insects could suppress the spread of infectious diseases, reducing health risks for local populations by up to 20% in affected areas.
🧬 バイオ研究
Tool for Gene Function Analysis
Infertile insects and related reagents could be offered as research tools for detailed analysis of the impact of nanosP gene function loss on insect development. This could contribute to basic biology research and the establishment of screening systems for novel pesticide development, potentially accelerating drug discovery by 1.5x.
Integration Roadmap — Estimated 24-Month Deployment
Basic Technology Validation & Target Selection
Duration: 5 months
Identify the nanosP gene in the licensee's target lepidopteran pest species and conduct initial validation of the sterilization effect.
Application Development & Pilot Trials
Duration: 11 months
Optimize the sterilization technology for the selected pest species, establish production processes, and conduct small-scale field trials at the farm level.
Mass Production & Market Launch
Duration: 8 months
Establish a mass production system for infertile insects, followed by large-scale practical application tests and full market introduction and deployment.
Technical Feasibility
This technology is based on genetic engineering to inhibit nanosP gene function, demonstrating high compatibility with existing insect rearing facilities and gene manipulation techniques. The patent claims suggest specific gene sequences and vector utilization, allowing for relatively easy technology adoption and validation using existing bio-research infrastructure. With foundational research completed by a national R&D institution, technical hurdles are low, and early practical application is anticipated.
Success Scenario
Upon adoption, this technology could enable licensees to reduce pesticide use for specific lepidopteran pests by up to 30% annually. This is expected to lower production costs and establish an environmentally conscious brand image. Furthermore, it is estimated to improve harvest losses due to pest damage by an average of 5-10% annually, building a stable agricultural product supply system. In the long term, it could also contribute to regional biodiversity conservation and enhance corporate ESG ratings.
Patent Record
APPLICATION NO.
特願2021-199311
REGISTRATION NO.
7667566
FILING DATE
2021/12/08
GRANT DATE
2025/04/15
EXPIRATION DATE
2041/12/08
PATENT HOLDER
国立研究開発法人農業・食品産業技術総合研究機構
Examination History
2023年09月26日
出願審査請求書
2024年10月08日
拒絶理由通知書
2024年12月04日
手続補正書（自発・内容）
2024年12月04日
意見書
2025年03月11日
特許査定